Hubei Goto Biopharm Co.,Ltd.

SZSE:300966.SZ

21.06 (CNY) • At close October 26, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q4
Assets:
Current Assets:
Cash & Cash Equivalents 304.3116.793181.974138.792162.821278.607438.418233.685454.889200.332209.914122.82172.635.31228.964084.639-129.664129.664
Short Term Investments 0.0010.0010.001-30.089-30.78510.00415.012-13.186-1.8610.1020.1010.10.10000.02259.3280
Cash and Short Term Investments 304.301116.794181.975138.792162.821288.611453.43233.685454.889200.434210.015122.92172.735.31228.964084.659129.664129.664
Net Receivables 266.772258.443257.34251.007297.249265.638307.399308.529282.879276.232263.098360.411346.693346.472342.5870266.7040205.881
Inventory 389.561370.733396.158442.095456.058475.048432.499426.117420.327405.412371.244261.924247.933216.391200.7390210.4690243.491
Other Current Assets 22.75426.73134.2618.52316.07533.99520.4049.75810.298.42713.8994.9939.1526.6527.35301.7808.609
Total Current Assets 983.388772.702869.732850.417932.2031,063.2921,213.732978.0881,168.385890.504858.257750.247776.478604.827579.6420563.611129.664587.645
Non-Current Assets:
Property, Plant & Equipment, Net 1,575.7461,524.5441,391.8761,065.459886.451740.433611.572495.901398.158292.791257.755194.877190.278194.91198.1050196.4160201.237
Goodwill 0000000000000000000
Intangible Assets 50.43850.71750.99526.72926.88526.96243.13827.35327.50927.66427.8227.97628.15320.93821.057021.148021.385
Goodwill and Intangible Assets 50.43850.71750.99526.72926.88526.96243.13827.35327.50927.66427.8227.97628.15320.93821.057021.148021.385
Long Term Investments 66.81948.12148.23577.99978.79638.07933.06961.32130.77928.78814.3714.30114.3000-000
Tax Assets 28.40423.54722.62222.85621.63419.54716.9078.5518.4818.3128.8224.5423.9673.2793.43504.36403.805
Other Non-Current Assets 67.67858.94964.281171.968160.423188.596149.899129.7292.58382.65744.21963.48931.7372.8082.18703.862-129.6643.61
Total Non-Current Assets 1,789.0851,705.8781,578.0091,365.0121,174.1891,013.616854.586722.846557.51440.213352.987305.185268.435221.935224.784816.292225.789-129.664230.036
Total Assets 2,772.4742,478.5792,447.7412,215.4292,106.3922,076.9082,068.3171,700.9341,725.8951,330.7181,211.2431,055.4321,044.913826.762804.427816.292789.40817.681
Liabilities & Equity:
Current Liabilities:
Account Payables 420.748501.949532.237359.652259.195187.888205.523157.097225.565150.254138.17376.25761.02642.64574.118084.0330134.218
Short Term Debt 380.525197.498132.816147.935178.213206.755328.849329.216310.045235.676154.876135.478161.521177.015139.7650157.4380147.321
Tax Payables 0.6262.0964.0843.9931.8017.1357.4855.8853.27210.11111.4038.1857.6589.7748.25709.52709.139
Deferred Revenue 1.1619.19316.59811.97210.21216.67618.95611.8058.05914.85822.56513.22916.01513.84312.52012.717013.38
Other Current Liabilities 6.4443.4864.7569.719.83632.18822.6399.9625.2944.17917.56728.3721.60522.4520.72504.14901.624
Total Current Liabilities 808.879712.126686.406529.259467.455443.507575.968508.08548.962404.966333.182253.335260.167255.953247.1270258.3370296.542
Non-Current Liabilities:
Long Term Debt 817.214643.468652.913611.706569.229577.764441.453239.005238.58325.5926.6656.7881.11.2651.312017.70100
Deferred Revenue Non-Current 105.49595.50184.32769.06569.27869.49269.70569.33169.54442.76842.9817.4537.3477.5197.6908.03208.375
Deferred Tax Liabilities Non-Current 0.0150.2570.2890.3231.2521.3530.0020-69.54400-7.45307.3-1.3120-17.70100
Other Non-Current Liabilities -105.4650.030.030000.049069.544007.4531.4240.0159.762017.701031.512
Total Non-Current Liabilities 817.259739.256737.559681.093639.76648.609511.209308.336308.12768.3649.64614.2419.87216.09917.452298.37425.733039.887
Total Liabilities 1,626.1381,451.3821,423.9651,210.3531,107.2151,092.1161,087.177816.416857.089473.326382.828267.576270.039272.052264.579298.374284.070336.429
Equity:
Preferred Stock 0000000000000000000
Common Stock 115.279115.279115.279115.278115.277115.277115.277115.277115.277115.277115.277115.277115.27786.27786.277086.277086.277
Retained Earnings 313.38323.888320.341320.123314.81301.343297.319297.048284.112285.853272.809251.424238.402212.153197.3590164.1660145.484
Accumulated Other Comprehensive Income/Loss 109.448517.65996.494517.836107.645515.474106.368418.9679.861418.9679.861416.0876.981250.905000481.2520
Other Total Stockholders Equity 408.9230420.6360409.1180409.1060409.1060409.1060409.1060250.9050249.4910249.491
Total Shareholders Equity 947.03956.826952.75953.237946.851932.095928.07831.293818.356820.097807.053782.788769.766549.335534.54512.542499.934481.252481.252
Total Equity 1,040.8411,027.1981,023.7761,005.076999.177984.792981.141884.518868.807857.392828.415787.856774.874554.71539.847517.917505.33481.252481.252
Total Liabilities & Shareholders Equity 2,772.4742,478.5792,447.7412,215.4292,106.3922,076.9082,068.3171,700.9341,725.8951,330.7181,211.2431,055.4321,044.913826.762804.427816.292789.4481.252817.681